Effects of Hydroxychloroquine Plus Favipiravir Treatment on the Clinical Course and Biomarkers in Hospitalized COVID-19 Patients with Pneumonia

Background: The novel coronavirus disease 2019 (COVID-19) has a broad spectrum of clinical manifestations, the most common serious clinical manifestation of the coronavirus infection being pneumonia. Unfortunately, the optimal treatment approach is still uncertain. However, many studies have been...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Leman Acun Delen, Abdullah Gok, Umut Sabri Kasapoğlu, Ozlem Cagasar, Zarife Gok, Nurcan Berber, Serdar Derya, Bora Tetik
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2022-01-01
Colecção:	Acta Clinica Croatica
Assuntos:	Favipiravir Hydroxychloroquine COVID-19 SARS-COV-2 Pneumonia
Acesso em linha:	https://hrcak.srce.hr/file/428402
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!